TABLE 1.
Baseline patient characteristics
| Demographic characteristica | Total cohort (n = 293) | Success (n = 224) | Failure (n = 69) | P value |
|---|---|---|---|---|
| Age (yr), mean ± SD | 60.54 ± 17.20 | 60.79 ± 17.5 | 59.72 ± 6.15 | 0.65 |
| Male, no. (%) | 276 (94.2) | 208 (92.9) | 68 (98.6) | 0.077 |
| Race, no. (%) | 0.95 | |||
| African American | 46 (15.7) | 36 (16.1) | 10 (14.5) | |
| Caucasian | 243 (82.9) | 185 (82.6) | 58 (84.1) | |
| Other | 4 (1.4) | 3 (1.3) | 1 (1.5) | |
| Ht (in.), mean ± SD | 69.82 ± 2.99 | 69.89 ± 3.04 | 69.55 ± 2.83 | 0.40 |
| Wt (kg), mean ± SD | 100.63 ± 26.50 | 98.88 ± 24.57 | 106.3 ± 31.5 | 0.043 |
| BMI (kg/m2), mean ± SD | 32.0 ± 7.89 | 31.32 ± 7.21 | 34.18 ± 9.49 | 0.0098 |
| Temp (°F), mean ± SD | 97.57 ± 0.94 | 97.55 ± 0.94 | 97.63 ± 0.92 | 0.55 |
| Diabetes, no. (%) | 107 (36.5) | 74 (33) | 33 (47.8) | 0.026 |
| Heart failure, no. (%) | 27 (9.2) | 16 (7.1) | 11 (15.9) | 0.027 |
| Mild liver disease, no. (%) | 18 (6.1) | 18 (8) | 0 | 0.15 |
| Charlson score, median (interquartile range) | 1 (0–2) | 1 (0–2) | 1 (0–3) | 0.048 |
| Chronic kidney disease, no. (%) | 26 (8.9) | 19 (8.5) | 7 (10.1) | 0.67 |
| Serum creatinine (mg/dl), mean ± SD | 1.06 ± 0.35 | 1.06 ± 0.35 | 1.08 ± 0.32 | 0.73 |
| Creatinine clearance (ml/min), mean ± SD | 114.05 ± 53.15 | 112.04 ± 51.44 | 120.66 ± 58.34 | 0.25 |
| MRSA colonization (n = 94), no. (%) | 8 (8.5) | 5 (7) | 3 (13) | 0.37 |
| Penicillin allergy, no. (%) | 29 (9.9) | 22 (9.8) | 7 (10.1) | 0.94 |
a
BMI, body mass index; MRSA, methicillin-resistant Staphylococcus aureus.